Intarcia Therapeutics is primed to file its potentially revolutionary diabetes drug delivery device after revealing positive cardiovascular safety results.
What benefits can wearable technology bring to healthcare? Dirk Poschenreider asks whether the growing pains and challenges it presents have been fully addressed.
This second article in the three-part series examining healthcare trends in Latin America considers the effects of ageing, chronic conditions and obesity on the region.
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.